Psychotropic Drugs Reemerging as Headache Medicines.
CNS Drugs September 1, 2024 DOI: 10.1007/s40263-024-01107-x (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Psychedelics Headache treatment Alternative medicine Neurological disorders Pain management |
| Citations | 2 |
| Key findings | The therapeutic value of classic psychedelics, ketamine, and cannabinoids for headache disorders requires nuanced consideration of the specific headache disorder, drug, and mode of use. |
Abstract
Scientific and public attention on the therapeutic effects of psychedelics and other psychoactive compounds in headache disorders has recently grown. The use and reported therapeutic effects of such treatments have long been reported, though formal clinical trials are only recently taking place. When considering how these substances might be further studied and eventually applied, it is important to consider the specific headache disorder, the particular drug, and the mode of use. No singular protocol will be applicable across all headache disorders and drugs. In this leading article, the nuance required to consider the value of classic psychedelics, ketamine, and cannabinoids as headache medicines is presented.